Oxford corona vaccine first trial and success


New York: The success of the human trial trial of a vaccine developed jointly by Oxford University and AstraZeneca Pharmaceuticals in the context of the spread of the corona virus. Authorities say they have successfully completed the first phase of Wakis’ human experiment.

The vaccine boosts human immunity to the virus, officials said.

The Oxford / Astracea corona vaccine is safe. The vaccine enhances immunity to the virus in patients at the initial trial. Work on the third round of trials is underway after the completion of the trial trials in the first two phases. At this stage, the strength of the vaccine against the corona virus is being evaluated. If the third trial is successfully completed, it will be given to the patients, officials said.

The corona wax experiment and more information have been published in the medical journal The Lancet.

Source link


Please enter your comment!
Please enter your name here